Streetbeat News

Analyst Ratings

RACE

JP Morgan analyst Ryan Brinkman has upgraded Ferrari (NYSE:RACE) from Neutral to Overweight and increased the price target from $385 to $525.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:12 pm

SQM

JP Morgan has downgraded Sociedad Quimica Y Minera (SQM) from Overweight to Neutral and reduced its price target from $55 to $44.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:09 pm

MT

JP Morgan analyst Dominic O'Kane has downgraded ArcelorMittal (NYSE:MT) from Overweight to Neutral, indicating a less optimistic outlook on the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:07 pm

NRIX

Jefferies has initiated coverage on Nurix Therapeutics with a Buy rating and set a price target of $41.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:02 pm

ANIP

ANI Pharmaceuticals (NASDAQ:ANIP) has been analyzed by 5 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target has decreased by 8.54% to $79.8. Analysts have adjusted their ratings and price targets, reflecting their views on the company's market standing. ANI Pharmaceuticals has shown positive revenue growth and strong financial health indicators.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 12:01 pm

VALN

Valneva (NASDAQ:VALN) has received mixed analyst ratings over the past three months, with a majority being bullish. The average 12-month price target is $24.5, down 3.92% from the previous average. Analyst Edward White from HC Wainwright & Co. has adjusted his price targets downward while maintaining a 'Buy' rating. Valneva faces challenges with revenue decline and high debt but shows strong net margins.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 12:01 pm

AX

Analysts have shared mixed views on Axos Financial (NYSE:AX) over the past three months, with a recent positive shift in price targets. The average 12-month price target has increased by 13.23% to $80.17. Analysts have adjusted their ratings and price targets, reflecting their response to Axos Financial's performance and market conditions. The company has shown strong financial performance with a 23.24% revenue growth rate, a net margin of 36.53%, and a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 12:01 pm

KMI

Analysts have mixed views on Kinder Morgan (NYSE:KMI) with recent ratings showing a slight bullish trend. The average 12-month price target has increased by 8.4% to $23.09. Kinder Morgan's financials reveal challenges in profitability and asset utilization, despite revenue growth.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 12:01 pm

MELI

Analysts have varied opinions on MercadoLibre (NASDAQ:MELI), with most being bullish or somewhat bullish. The average 12-month price target has increased by 10.91% to $2388.44. MercadoLibre shows strong financial performance with high revenue growth, net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 12:00 pm

CPT

Jefferies has initiated coverage on Camden Property Trust (NYSE:CPT) with a Hold rating and set a price target of $123.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:00 pm